Morningstar

Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program

GOTHENBURG, Sweden, March 31, 2026 /PRNewswire/ -- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare ...
IEEE

PHNet: A Pulmonary Hypertension Detection Network Based on Cine Cardiac Magnetic Resonance Images Using a Hybrid Strategy of Adaptive Triplet and Binary Cross-Entropy Losses

Abstract: Pulmonary hypertension (PH) is a fatal pulmonary vascular disease. The standard diagnosis of PH heavily relies on an invasive technique, i.e., right heart catheterization, which leads to a ...
hospitalhealthcare

Early recognition of pulmonary hypertension and specialist referral pathways

Pulmonary hypertension is a condition where specialist input is essential, yet the day-to-day management of many patients takes place in local hospitals, usually in general respiratory clinics, far ...
ahajournals.org

THBS4 Regulates Pulmonary Hypertension via TGF-β/SMAD2 Signaling

Pulmonary hypertension (PH) is a progressive disease marked by pulmonary arterial remodeling and right ventricular dysfunction. The molecular mechanisms driving this remodeling, particularly ECM ...